Southern RNA supports early-phase clinical trials, providing research-grade RNA to GMP-aligned and clinical-grade material. Our approach ensures continuity across development and quality oversight, enabling efficient progression to first-in-human studies.
Our clinical trial capabilities are tailored for innovators bridging research and early clinical testing. We work with founders, translational teams, and sponsors who need scalable RNA solutions with integrated quality and regulatory support.
We support startups and emerging companies that require reliable RNA supply for first-in-human studies. Our integrated services reduce risk, streamline timelines, and provide the technical expertise needed to progress novel therapeutics efficiently.
Our solutions are designed for teams bridging laboratory discovery to clinical application. By providing consistent, high-quality RNA and robust analytical support, we help translational scientists move programmes confidently towards early-phase trials.
We partner with clinical sponsors who need scalable, regulatory-ready RNA material. Our GMP-aligned and clinical-grade capabilities, combined with quality and documentation systems, ensure compliance and traceability from research through to early clinical supply.
We have successfully scaled GMP-aligned mRNA for multiple FIH trials, delivered consistent high-purity plasmid DNA and mRNA, and developed analytical methods supporting regulatory submissions. Our experience ensures reliable and compliant early-phase supply.
Successfully scaled GMP-aligned mRNA for multiple first-in-human trials
Delivered consistent, high-purity plasmid DNA and mRNA for early clinical studies
Developed and validated analytical methods supporting regulatory submissions
Demonstrated capability to maintain continuity from early research through FIH supply
Proven track record of collaboration with academic and industry translational teams
We support first-in-human and early-phase trials with GMP-aligned and clinical-grade RNA, scalable manufacturing, analytical testing, and full documentation. Our solutions help accelerate timelines while maintaining compliance and minimising risk during critical early-stage studies.
